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Background: In Madagascar, the last study on sickle cell disease (SCD) was done in the early 1980s. The country is
known as endemic for malaria and respiratory infections. The main objective of this study was to estimate the
prevalence of SCD; the secondary objective was to evaluate its association with malaria and respiratory infections.
Methods: This is a cross-sectional study which was carried out in a rural village in the south east coast of
Madagascar between May 2011 and November 2013. Participants were children aged between 2–59 months
presenting with fever measured by axillary temperature ≥37.5 °C at inclusion. Genotyping of haemoglobin S was
done by PCR and malaria was diagnosed by Rapid Diagnostic Test. Research for viral and atypical bacterial
respiratory pathogens was performed on nasopharyngeal swabs. Uni-and multivariate polytomous logistic
regression was done to assess associations between microbiological results and SCD status, with HbAA phenotype
as reference.
Results: A total of 807 children were analysed. Prevalence of SCD among febrile children was 2.4% (95% CI, 1.5–3.
7%) and that of SCT was 23.8% (95% CI, 20.9–26.9%). There was no difference in the prevalence of malaria infection
according to haemoglobin status (p = 0.3). Rhinovirus (22.5%), adenovirus (14.1%), and bocavirus (11.6%) were the
most common respiratory pathogens detected. After univariate analysis, patients with SCD were more frequently
infected by parechovirus (p = 0.01), while patients with SCT were more prone to RSV A or B infection (p = 0.01).
After multivariate analysis, HbAS phenotype was associated with higher risk of RSV A and B infection compared to
HbAA (adjusted OR = 1.9; 95% CI: 1.2–3.1, p = 0.009), while HbSS phenotype was associated with higher risk of
parechovirus infection (adjusted OR = 6.0; 95% CI: 1.1–31.3, p = 0.03) compared to HbAA, independently of age,
gender, period per quarter, and the other viruses.
Conclusion: The prevalence of SCD among under-five children presenting with fever was high in the study
population. No association was found between SCT and malaria but few viruses, especially parechovirus, seem to
play an important role in the occurrence of pneumoniae among SCD patients.
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During its 59th World Health Assembly held in 2006,
WHO recognized sickle-cell disease (SCD), an inherited
disorder of haemoglobin as a priority of public health. A
resolution was adopted to develop and strengthen efforts
for its prevention and management. Sickle-cell anaemia,
one of the most common forms of SCD, is due to a
point mutation within the sixth codon of the β-globin
chain. The produced abnormal variant – haemoglobin
S (HbS) – is responsible for chronic haemolytic an-
aemia and vaso-occlusion which are the underlying
causes of the clinical presentation of SCD. Individuals
who express the homozygous form (HbSS) manifest the
disease, while those with the heterozygous form
(HbAS), also known as sickle-cell trait (SCT), are usu-
ally asymptomatic carriers.
Initially limited to the sub-Saharan Africa, the Middle-
East and some parts of India [1], SCD has currently
spread to all continents with the migration of popula-
tions. The βS-globin gene is found on five common hap-
lotypes in Africa (Bantu, Benin, Cameroon and Senegal)
and Asia (Saudi Arab-Indian) [2] that can be used as a
marker of genetic diversity and population origin. Ap-
proximately 300,000 children with severe haemoglobin
disorders are born every year worldwide [3] and over
75% of SCD occur in Africa where carrier frequency
ranged from 1% (Central African Republic, Senegal) to
38% (United Republic of Tanzania) [1]. In Madagascar,
several studies conducted in 1950s had estimated the
general prevalence of SCD from 4% in the Central
highlands [4] to 11-13% in the South-eastern coast
[5]. Significant ethnical variation and high prevalence
in asymptomatic carrier up to 28% were also reported
[6]. To our knowledge, the last published study was
done in the early 1980s [7]. These studies, however,
were based on the detection of sickle red blood cells
in hypoxic conditions, also known as “sickling test”,
and the sickle solubility test [3] now considered as
obsolete techniques.
In area where malaria is endemic, its relation with
SCT was often studied, in particular the high degree of
resistance to severe and complicated malaria in sickle
cell trait [8, 9]. Malaria is endemic in Madagascar with
strong and persistent transmission in the east coast [10].
From May 2011 to November 2013, a cross-sectional
study was conducted in the rural village of Ampasiman-
jeva in the south east cost of Madagascar aiming to
identify blood-borne protein biomarkers that can differ-
entiate the causes of unexplained acute febrile illness in
children. The study site is known for its high endemicity
to malaria, acute respiratory infections and SCD. The
main objective of this study was to estimate the preva-
lence of SCD; the secondary objective was to evaluate its
association with malaria and respiratory infections.Methods
Study design and population
This is an observational cross-sectional study with pro-
spective data collection of children aged between 2 to
59 months presenting with fever (axillary temperature
≥37.5 °C according to WHO criteria). The study was
conducted from May 2011 to November 2013 in the
rural village of Ampasimanjeva located in the south east
cost of Madagascar. Ampasimanjeva is 320 km away
from the capital city Antananarivo with a total inhabit-
ant estimated to be 22,000 according to the last census.
The east coast has hot and humid subequatorial climate
and an annual high cumulative rainfall of 4,000 mm per
year. Transmission of malaria in this region is reported
to be strong and intense all over time. A standardized
questionnaire on socio-demographic and clinical data
was fulfilled for each individual. The Ampasimanjeva
community hospital is a Hospital District Centre receiv-
ing each year around 950 children between 2 and 5 years
old. Acute Respiratory Infections were the main cause of
morbidity accounting for 35% of consultation all ages
combined.
Ethical approval for the study was obtained from the
National Ethical Committee of the Ministry of Health of
Madagascar (authorization 019-CE/MINSAN as of 09/
04/2010). Individual written informed consent was pro-
vided by the parents of all study participants.
Sample collection
For each child, venous blood was collected with safety
blood containers on dry and spray-dried EDTA. The sam-
ples were transported in a refrigerated container at +4 °C
to the Centre d’Infectiologie Charles Mérieux for analysis.
Transport of samples was organized twice a week.
Genotyping of haemoglobin
After DNA extraction (QIAamp DNA Mini Kit, Qiagen,
Germany) of the EDTA blood samples, the mutation re-
sponsible for the generation of HbS was identified by
Restriction Fragment Length Polymorphism (RFLP)
assay of PCR-amplified DNA (Bio-Rad, USA) [11]. The
RFLP pattern of the normal profile (HbAA) of healthy
subject is characterized by the presence of the restriction
endonuclease DdeI site and cleaved in 2 fragments (189
and 93 bp). The homozygous profile (HbSS) responsible
of the disease has no restriction site and only one frag-
ment of 282 bp is observed. The heterozygous profile
(HbAS) also known as sickle-cell trait combines restric-
tion and no restriction site and reveals 3 fragments (93,
189, and 282 bp).
Malaria assays
Rapid Diagnostic Test (RDT) of malaria was performed
on site using CareStart™ Malaria (Access Bio, Inc., New
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scopically from the positive samples as previously de-
scribed [12].
Detection of respiratory pathogens
Bacterial and viral DNAs as well as viral RNA were ex-
tracted from the nasopharyngeal swabs using RTP® Patho-
gen kit (STRATEC Molecular, Germany). A multiplex real-
time PCR assay allowing the identification of 22 respiratory
pathogens (Fast-track Diagnostics respiratory pathogens kit,
FTD Luxembourg) was used as previously described [13].
Following nucleic extraction of EDTA-whole blood samples,
another multiplex real-time PCR assay was performed to
identify Staphylococcus aureus, Streptococcus pneumoniae
and Haemophilus influenzae type b as previously described
[14]. All RNA/DNA amplifications and detections were
done using Bio-Rad CFX96 machine (Bio-Rad, USA).
Statistical analysis
Categorical variables were described as number and per-
centage with their 95% confidence intervals (CI); continuous
covariates were described as median and interquartile range
(IQR). The Chi2 test or Fisher’s exact test was used to
compare categorical variables. Continuous covariates were
compared by Mann–Whitney U-test or Kruskal–Wallis
one-way analysis of variance. Univariate and multivariate
polytomous logistic regression analysis was done to assess
microbiological results associated with haemoglobin status,
where the normal phenotype was the reference (HbAA).
Statistical analyses were done using Epi Info™ 7.1.3
(Centers for Disease Control and Prevention, Atlanta,
Georgia) and Stat 13.0 (StataCorp). All tests were 2-tailed
and a p-value of less than 0.05 was considered significant.
Results
Sample size of eligible children
There were 862 children enrolled in the survey. Among
them, 55 were excluded because not meeting the age
and temperature criteria and because of inadequate
blood sample. Subsequently, a total of 807 children were
selected for the final analysis.
Demographic and health status
Out of the 807 children participating in the survey, 401
(49.7%) were male and the median age was 20 months
(IQR: 10–36 months). The median temperature at inclu-
sion was 38.8 °C (IQR: 38.5–39.4 °C). To assess the weight
gain and growth, anthropometric parameters of children
were measured [15]. The median upper arm circumfer-
ence was 140 mm (IQR: 132–146 mm). The median
weight-for-height Z-score was−1.5 (IQR:−2,2; 0.7); and
245 (30.5%) had weight-for-height Z-score ≤−2SD. The
main reasons for medical consultation were malaria
(36.6%), pneumonia (33.2%), acute respiratory infection(28.5%), and asthma (1.6%). Pneumococcal Conjugate Vac-
cine was introduced in 2012 and the national coverage
was 76% in 2013 according to WHO and UNICEF esti-
mates. However no information on the vaccination status
against S. pneumoniae is available among the study
population.
Genotyping of haemoglobin S
To identify the genotype of haemoglobin, the PCR-
products from all 807 blood samples were digested and
analyzed by the RFLP method. The results of the first
100 genotyping assay were compared to those of the
electrophoresis of haemoglobin on alkaline (pH 8.5)
agarose gels (Hydragel 7 Hemoglobine, Sebia, Evry,
France) and 100% concordant identification was ob-
served (data not shown). Overall, 73.9% (95% CI, 70.7–
76.8%) children expressed the normal phenotype HbAA,
whereas the prevalence of SCT (heterozygous HbAS)
was 23.8% (95% CI, 20.9–26.9%) and that of SCD
(homozygous HbSS) was 2.4% (95% CI, 1.5–3.6%).
To classify the nutritional status of the study popula-
tion, we evaluated the mean weight-for-height Z-score.
Individuals with HbSS showed a lower value [−2.2 SD
(−3.4;−1.2)] compared to those with HbAS [−1.2 SD
(−2.2;−0.5)] or HbAA [−1.5 SD (−2.2; −0.7)] phenotypes
(p = 0.02), suggesting a state of undernutrition (Table 1).
These findings were supported by a significant difference
in the values of mid-upper arm circumference between
the 3 groups (p = 0.001). We also found a higher preva-
lence of males among individuals with HbSS (68.4%)
compared to the HbAS (42.7%) and HbAA (51.3%)
groups (p = 0.03).
Malaria RDT and microscopy
Out of the 807 children, RDT showed 295 (36.6%; 95%
CI, 33.3–39.9%) positive results of which 273 Giemsa-
stained thick smear tests were done. The microscopic
results showed that 197/273 (72.2%) infections were
caused by Plasmodium falciparum, 2/273 (0.7%) were
due to both P. falciparum and P. vivax, and the others
were negative (74/273, 27.1%). There was no association
between haemoglobin status and malaria infection
(Table 1). Strikingly, no children with HbS below 2 years
of age were infected; however, a trend in an increased
detection rate of P. falciparum in older children with
HbAS and HbSS was observed (Fig. 1).
Respiratory pathogens infection
Overall, 698 (91.4%; 95% CI, 89.1–93.2%) were positive
for at least 1 bacterial pathogen and 575 (75.3%; 95% CI,
72.1–78.3%) for at least 1 viral pathogen. Co-detection
of at least two viruses or both bacteria and virus was ob-
served in 186 (24.4%; 95% CI, 21.4–27.6%) and 527
(69.0%; 95% CI, 65.5–72.2%) of cases, respectively.
Table 1 Characteristics of study population by haemoglobin phenotype
Characteristics HbAA (n = 596) HbAS (n = 192) HbSS (n = 19) p
Period, quarter, N (%)
- January-March 72 (12.1) 31 (16.1) 3 (15.8) 0.19
- April-June 195 (32.7) 57 (29.7) 7 (36.8)
- July-September 135 (22.6) 54 (28.1) 6 (31.6)
- October-December 194 (32.5) 50 (26.0) 3 (15.8)
Age, months, median (IQR) 21.0 (10.5–36.0) 20.0 (9.0–36.5) 17.0 (10.0–33.0) 0.50
Age category, months, n (%)
- 2–11 160 (26.8) 62 (32.3) 6 (31.6) 0.68
- 12–23 152 (25.5) 45 (23.4) 5 (26.3)
- 24–59 284 (47.7) 85 (44.3) 8 (42.1)
Gender, n (%)
- Male 306 (51.3) 82 (42.7) 13 (68.4) 0.03
- Female 290 (48.7) 110 (57.3) 6 (31.6)
Temperature, °C, median (IQR) 38.8 (38.6–39.4) 38.8 (38.6–39.4) 38.5 (38.0–38.7) 0.11
Height, cm, median (IQR) 78.0 (71.0–87.0) 77.0 (69.5–86.0) 74.0 (69.0–86.0) 0.18
Weight, kg, median (IQR) 9.5 (8.1–11.6) 9.3 (7.9–11.4) 8.5 (7.2–10.0) 0.61
Mid-upper arm circumference, cm, median (IQR) 140 (133–146) 140 (132–148) 128 (117–136) 0.001
Weight-for-height Z-score ≤2 SD −1.5 (−2.2; −0.7) −1.2 (−2.2; −0.5) −2.2 (−3.4; −1.2) 0.02
Positive RDT malaria, n (%) 227 (38.1) 63 (32.8) 5 (26.3) 0.3
Naso-pharyngeal carriers positive detection, n (%)
- Parechovirus 9 (1.6) 1 (0.6) 2 (11.1) 0.02
- RSV A and B 56 (9.8) 30 (17.0) 0 (0) 0.01
- Human coronavirus 229E 6 (1.1) 0 (0) 1 (5.6) 0.07
- Viral coinfection 144 (25.3) 34 (19.2) 8 (44.4) 0.03
S. pneumoniae positive from blood, n (%) 11 (1.9) 3 (1.6) 1 (5.3) 0.5
* HbAA, normal phenotype, HbAS sickle cell trait, HbSS sickle cell disease
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95% CI, 86.4–91.0%) and reached all (100%) children in
the HbSS group compared to the HbAS (89.8%; 95% CI,
84.4–93.9%) and HbAA (88.2%; 95% CI, 85.2–90.7%)
groups.
Out of 764 nasopharyngeal samples tested, rhinovirus
(22.5%; 95% CI, 19.7–25.6%; n = 172), adenovirus (14.1%;
95% CI, 11.8–16.8%; n = 108), bocavirus (11.6%; 95% CI,
9.6–14.1%; n = 89), respiratory syncytial virus A or B
(11.3%; 95% CI, 9.2–13.7%; n = 86), and human metap-
neumovirus A and B (9.0%; 95% CI, 7.1–11.3%; n = 69)
were the most common respiratory pathogens detected;
Chlamydia pneumoniae and Mycoplasma pneumoniae
accounted for < 2.0% of cases (Fig. 2).
Parechovirus was most frequently detected from re-
spiratory sample in HbSS patients (n = 2, 11.1%) com-
pared to the HbAA (n = 9, 1.6%) and HbAS (n = 1, 0.6%)
patients (p = 0.02). Similar results were observed with
human coronavirus 229E where patients in the HbSS
group yielded high positive result (n = 1, 5.6%) compared
to the HbAA (n = 6, 1.1%) and HbAS (n = 0) groups(p = 0.07) (Table 1). Conversely, respiratory syncytial
virus A and B infection were more frequent in HbAS
individuals (n = 30, 17.0%) compared to HbAA (n = 56,
9.8%) and HbSS (n = 0) patients (p = 0.01). Viral coinfec-
tion were frequent in the HbSS group (n = 8, 44.4%) com-
pared to the HbAA (n = 144, 25.3%) and HbAS (n = 34,
19.2%) groups (p = 0.03).
Univariate polytomous regression disclosed the risk of
respiratory syncytial virus A and B which was 2-fold
more higher in HbAS compared to HbAA groups (crude
odds ratio [OR] = 1.9; 95% CI: 1.2–3.0, p = 0.01), and the
risk of parechovirus infection which was higher in HbSS
compared to HbAA groups (crude OR = 7.8; 95% CI:
1.6–38.9; p = 0.01) [Table 2]. After multivariate analysis,
HbAS compared with HbAA phenotype remained asso-
ciated with higher risk of RSV A and B infection (ad-
justed OR = 1.9; 95% CI: 1.2–3.1, p = 0.01),
independently of age, gender, period per quarter, and
parechovirus infection. HbSS compared with HbAA
phenotype remained associated with higher risk of
parechovirus infection (adjusted OR = 6.0; 95% CI: 1.1–
Table 2 Microbiological findings associated with heamoglobin status, univariate polytomous logistic regression
Microorganism Heterozygous form HbAS (n = 177) Homozygous form HbSS (n = 19)
Crude odds ratio (95% CI)* p Crude odds ratio (95% CI)* p
> = 1 bacteria from blood 0.8 (0.4–2.0) 0.7 3.8 (1.04–14.2) 0.04
> = 1 bacteria from respiratory sample 1.2 (0.6–2.2) 0.62 NE –
> = 1 virus from respiratory sample 0.9 (0.6–1.3) 0.57 0.5 (0.2–1.3) 0.15
Coinfection from respiratory sample 0.9 (0.6–1.3) 0.65 0.7 (0.3–1.8) 0.44
Viral coinfection from respiratory sample 0.7 (0.5–1.1) 0.1 2.4 (0.9–6.1) 0.08
Blood
S. pneumoniae 0.8 (0.2–3.1) 0.8 3.0 (0.4–24.1) 0.31
S. aureus, 0.8 (0.2–3.1) 0.8 3.0 (0.4–24.1) 0.31
H. influenzae 0.4 (0.05–3.6) 0.44 4.7 (0.5–40.0) 0.16
Respiratory sample
S. pneumoniae 1.2 (0.7–2.0) 0.56 NE –
S. aureus 1.6 (0.9–2.9) 0.14 1.9 (0.4–8.4) 0.42
H. influenzae 1.0 (0.6–1.7) 0.85 0.4 (0.05–3.0) 0.37
Mycoplasma pneumoniae 0.6 (0.07–5.5) 0.68 NE −
Chlamydia pneumoniae 2.3 (0.7–7.4) 0.15 NE −
Respiratory syncytial virus A and B 1.9 (1.2–3.0) 0.01 NE −
Human metapneumovirus A and B 0.6 (0.3–1.1) 0.11 NE −
Human rhinovirus 1.0 (0.7–1.5) 0.9 1.8 (0.6–4.8) 0.27
Human parainfluenzavirus 1 0.9 (0.4–2.0) 0.73 NE −
Human parainfluenzavirus 2 1.2 (0.4–3.5) 0.68 NE −
Human parainfluenzavirus 3 1.2 (0.5–2.9) 0.7 1.7 (0.2–13.5) 0.6
Human parainfluenzavirus 4 0.5 (0.06–4.5) 0.56 NE −
Human coronavirus 229E NE − 5.5 (0.6–48.4) 0.12
Human coronavirus NL63 1.2 (0.4–3.2) 0.79 NE −
Human coronavirus OC43 0.5 (0.2–1.4) 0.21 1.1 (0.1–8.5) 0.93
Human coronavirus HKU1 1.2 (0.3–4.6) 0.78 NE −
Influenza virus A NE − NE −
Influenza virus A (H1N1)/pdm09 0.2 (0.03–1.7) 0.15 2.3 (0.3–18.8) 0.43
Influenza virus B 0.9 (0.4–2.2) 0.88 NE −
Human parechovirus 0.4 (0.04–2.8) 0.32 7.8 (1.6–38.9) 0.01
Human adenovirus 1.0 (0.6 (1.7) 0.94 1.8 (0.6–5.5) 0.32
Human bocavirus 0.7 (0.4–1.3) 0.24 1.4 (0.4–5.0) 0.58
Enterovirus 0.5 (0.2–1.1) 0.09 0.7 (0.09–5.4) 0.73
*After polytomous univariate logistic regression, compared with normal form HbAA (n = 569)
NE, non estimable
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quarter, and RSVA and B infection.
Out of the 807 whole blood samples tested, invasive
pneumococcal disease was reported in 15 patients (1.9%;
95% CI, 1.1–3.3%). All of them recovered well without
complication.
Discussion
Our study shows that prevalence of SCD was 2.4% and
that of SCT 23.8% among children aged 2–59 monthspresenting with fever and living in high endemic area for
malaria. To our knowledge, this study is the first to
document the prevalence of HbSS in febrile young chil-
dren. Although no similar age group is available for
comparison, previous results report high carrier rate of
29.6% to 31.9% [16, 17] from the same ethnic group in
which the βS-globin gene frequency was reported to be
0.159 [17]. We cannot certify however the ethnicity of
our studied population because it has not been queried
during the investigation. In an extensive study of 1,214
Fig. 1 Prevalence of malaria-infected children by age group and haemoglobin status
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conducted in 2007 (Institut Pasteur de Madagascar, un-
published data), a much lower prevalence of 0.2% for
HbSS and 9.4% was found for the heterozygous state
compared to our study. When data from the South-east
coast only is selected in this later study, the prevalence
of HbSS is 0.7% and that of the heterozygous state is
18.7%, slightly lower than that observed in our study.
While these data show a higher SCT prevalence amongFig. 2 Viral respiratory and atypical bacteria pathogens detected in the nas
phenotype. HRV: human rhinovirus; HAdV: human adenovirus; HBoV: huma
parainfluenzavirus 1, 2, 3 or 4; hMPV: human metapneumovirus A or B; HCo
FLU: influenza viruses A, B or A (H1N1)/pdm09; HPeV: human parechovirus;the study population in Madagascar, further study is
needed to estimate the real burden among the general
population.
Our results demonstrate a significantly lower mean
weight-for-height Z-score for patients with SCD than those
of normal children and individuals with SCT. Previous
studies from other developing countries have reported a
state of undernutrition among patients with SCD [18, 19]
that may lead to slow growth and maturational abnormality,opharyngeal swabs of study children according to haemoglobin
n bocavirus; RSV: respiratory syncytial virus A and B; hPIV: human
V: human coronaviruses NL63, 229E, OC43 or HKU1; HEV: enterovirus;
Cpneu: Chlamydia pneumoniae; Mpneu: Mycoplasma pneumoniae
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ous observations that nutritional supplementation is a
major component in the management of SCD.
Studies reporting gender differences in SCD incidence
are rare and mainly focus on the occurrence of crises or
comorbidities [21, 22]. However, in a cross-sectional
study carried out over 735 students in India, the preva-
lence of SCT using the sickling test was higher among
male (7.3%) compared to that among female (5.9%) [23].
Our study found higher SCD prevalence among male
population, but no significant difference between male
and female for SCT prevalence. This should be taken
into account in the gender-selective use of medical facil-
ities and management of patients.
Previous studies have shown that SCT protects against
severe forms [8] and mild malaria infections [24, 25], al-
though the precise mechanism remains poorly under-
stood. In our study, a high proportion of P. falciparum
positive result (36.6%) has been found among the stud-
ied population. Overall, we did not find any statistical
difference between malaria-infected children in the
HbAS group compared to the normal phenotype. How-
ever, as the age increases, the frequencies of children in
the HbAS and HbSS groups who experienced malaria in-
creases. The absence of malaria infection in the patients
with SCD up to 2 years of age may have several causes
including an early death due to malaria or other
infections.
Individuals with SCD are strongly susceptible to en-
capsulated bacterial organisms such as S. pneumoniae, a
common colonizer of the nasopharynx in healthy chil-
dren. Here we report a very high pneumococcal carriage
rate among the febrile children studied. Strikingly, all
children (100%) with homozygous sickle cell disease in
our study were carriers. In previous reports, a much
lower rate was found in the US (12%) [26] and Uganda
(33%) [27] during study conducted on patients with
homozygous sickle cell disease. In our study, pneumonia
and acute respiratory infections were the main reasons
for medical consultation after malaria. However, the role
of S. pneumoniae in the development of the disease in
the majority of patients is hypothetical due to the ab-
sence of healthy matched control group. It should be
mentioned that 1.9% of the patients had bacteraemia
with S. pneumoniae during the course of infection but
its causative role has not been proven up as up to 5% of
febrile children may also develop asymptomatic or oc-
cult bacteraemia [28].
The overall prevalence of viral infection/detection
among the study population was high independent of
haemoglobin status. However, among the 23 viral and
atypical bacteria pathogens studied, there was no statis-
tical difference in prevalence between the three groups
for 20 of them and include HRV the most commonrespiratory virus detected or influenza virus A (H1N1)/
pdm09 known to increase disease severity in children
with SCD [29]. Parechovirus, a member of the family
Picornaviridae, was significantly associated with a high
risk of infection in SCD patients in our study. Parecho-
virus infections are usually asymptomatic or lead to a
mild gastro-intestinal or respiratory diseases. Only two
patients had parechovirus detected, both presenting with
symptoms of pneumoniae, suggesting that larger pro-
spective study is required to better describe the real im-
pact of parechovirus infection among SCD population.
Conversely, RSV A or B belonging to the family Para-
myxoviridae, was significantly associated with a high risk
of infection in SCT patients compared to the normal
population whereas no virus was detected in SCD pa-
tients. RSV A and B are a major cause of lower respira-
tory tract infection during infancy and childhood and
were associated with acute chest syndrome similar in se-
verity to influenza infection in febrile children with SCD
[30]. The reason why RSV A and B were not detected in
our study using a sensitive molecular tool is unknown
but it may be linked either to the small number of iden-
tified SCD patients, or the possible death of those chil-
dren. However no follow-up of the study population was
carried out to ascertain the latter hypothesis.
Detection of respiratory viruses has been facilitated by
the recent widespread availability of nucleic acid amplifi-
cation techniques. In a study carried out previously in
Ampasimanjeva to describe the aetiology of a clinically de-
fined cohort of children with fever and acute respiratory
infections, the most representative pathogens were human
metapneumovirus (hMPV) for pneumonia, human parain-
fluenzavirus (hPIV) for other acute lower respiratory
infections, respiratory syncytial virus (RSV) for flu-like
illnesses and human adenovirus (HAdV) for upper re-
spiratory tract infections [13]. However, the clinical signifi-
cance of viral detection in biological samples from
patients with respiratory infections remains often unclear.
For example, when detected in a patient with severe pneu-
monia, respiratory viruses may represent subclinical infec-
tion, persistent shedding after a prior infection, infection
restricted to the upper respiratory tract, or infection in-
volving the lower respiratory tract [31–33]. While some
pathogens, such as RSV, hMPV and FLU seem to be strict
pathogens, other viruses such as HRV are widely identified
in both cases and controls. It was beyond the scope of this
study to evaluate the viral distribution in asymptomatic
patients to study proportion of viral shedding in a control
group, or to distinguish between upper and lower respira-
tory tract infections. Nevertheless, the same study con-
ducted a year ago in the same population has confirmed
our findings that a wide range of respiratory viruses might
have played a role in escalating respiratory tract viral in-
fections among patients with SCD and SCT.
Maeder et al. BMC Hematology  (2016) 16:30 Page 8 of 9Our study was limited by the fact that the genotyping
method used may not be totally specific to detect
haemoglobin S as the presence or the absence of the re-
striction site DdeI may be found in other hemoglobinop-
athies. However, according to one recent publication
[34], HbS seemed to be the most prevalent in Africa
where over 700 haemoglobin variants were identified.
Additionally, the association between sickle cell trait and
malaria is not conclusive for the following reasons: the
initial design was probably not optimal to detect this as-
sociation in the current study, and more accurate
methods for detecting HbS should have been used (i.e.
hemoglobin electrophoresis). Further independent and
well-structured research should be considered in that
matter. A second limitation of this study is the absence
of long-term follow-up to estimate the outcomes of chil-
dren and the proportion and causes of death mainly
among those living with SCD.
Conclusion
Our findings show that the prevalence of SCD among
under-five children presenting with fever was high and a
better knowledge of the role and distribution of viral
and atypical bacteria pathogens in the study population
has been found. This study has helped moving towards a
better understanding of the epidemiology of SCD, and
we hope it will trigger further research in that direction,
for the following reasons. Firstly, as SCD is a major pub-
lic health concern in Madagascar, a large prospective
study on the general population to estimate the true
magnitude of the disease should be done. Secondly, it is
important to document data about the clinical course
and mortality associated to SCD in regions where it is
endemic. Thirdly, study involving increasing laboratory
capacity should be conducted to help a better under-
standing of SCD epidemiology, as well as other hemo-
globinopathies. Finally, conclusions from these studies
will be used for awareness-raising among national au-
thorities in order to strengthen the national control
program.
Abbreviations
SCD: Sickle-cell disease; SCT: Sickle-cell trait; HbSS: Homozygous sickle
haemoglobin; HbAS: Heterozygous sickle haemoglobin; HbAA: Normal
haemoglobin; RFLP: Restriction Fragment Length Polymorphism assay;
RDT: Rapid Diagnostic Test
Acknowledgments
This work was supported by grants from the Fondation Mérieux, Lyon,
France. The authors thank the children’s families for their consent to
participate in this study, and the entire medical staff at Medical Foundation
of Ampasimanjeva for assistance and cooperation. This paper is dedicated to
Doctor Bénédicte Contamin who died in August 2015 for her complete
devotion to patients.
Availability of data and materials
The datasets supporting the conclusions of this article are available at the
supplemental materials.Authors’ contributions
MNM, JH and ORA contributed to the design of the study, participated in
data collection and analysis; MRA, TB, PV, and JH contributed to data analysis
and writing of the final manuscript; HMR, NJZ, TR and ATR carried out the
experimental work and analyzed the data; MRR acquired data and
contributed to the clinical management of patients. All authors read and
approved the final version.Competing interests
The authors declare that they have no competing interests.
Author details
1Centre d’Infectiologie Charles Mérieux, Université Antananarivo, P.O. Box
4299, Antananarivo, Madagascar. 2Fondation Médicale d’Ampasimanjeva,
Manakara, Madagascar. 3UPFR Biochimie-Centre Hospitalier Universitaire
Joseph Ravoahangy Andrianavalona, Antananarivo, Madagascar. 4Laboratoire
des Pathogènes Emergents, Fondation Mérieux, Centre International de
Recherche en Infectiologie (CIRI), Inserm U1111, CNRS UMR5308, ENS de
Lyon, UCBL1 Lyon, France. 5Service d’Hygiène, Epidémiologie et Prévention,
Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. 6UPFR
Hématologie-Centre Hospitalier Universitaire Joseph Ravoahangy
Andrianavalona & Département de Microbiologie, Faculté de Médecine,
Antananarivo, Madagascar.
Received: 19 May 2016 Accepted: 17 November 2016
References
1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing
global health problem. Bull World Health Organ. 2001;79:704–12.
2. Rumaney MB, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Kengne AP,
Ngogang J, et al. The co-inheritance of alpha-thalassemia and sickle cell
anemia is associated with better hematological indices and lower
consultations rate in Cameroonian patients and could improve their
survival. PLoS ONE. 2014;9, e100516.
3. Makani J, Ofori-Acquah SF, Nnodu O, Wonkam A, Ohene-Frempong K.
Sickle cell disease: new opportunities and challenges in Africa. Sci
World J. 2013;2013:16.
4. Saugrain J. Initial research on sicklemia in Madagascar. Bull Société Pathol
Exot Ses Fil. 1954;47:844–84.
5. Chabeuf M, Zeldine G. Blood groups and drepanocytosis on Saint Mary’s
Island (Madagascar). Médecine Trop Rev Corps Santé Colon. 1962;22:261–7.
6. Saugrain J. New research on drepanocytosis in Madagascar. Bull Société
Pathol Exot Ses Fil. 1957;50:480–6.
7. Cerf P, Moyroud J, Coulanges P. Epidemiological survey and sanitary
problems in a village in East Central Madagascar. Arch Inst Pasteur
Madagascar. 1981;48:151–61.
8. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, Ter Kuile FO, Kariuki S, et al.
Protective effects of the sickle cell gene against malaria morbidity and
mortality. Lancet. 2002;359:1311–2.
9. Luzzatto L. Sickle cell anaemia and malaria. Mediterr J Hematol Infect Dis.
2012;4, e2012065.
10. Mouchet J, Blanchy S, Rakotonjanabelo A, Ranaivoson G, Rajaonarivelo E,
Laventure S, et al. Epidemiological stratification of malaria in Madagascar.
Arch Inst Pasteur Madagascar. 1993;60:50–9.
11. Kulozik AE, Lyons J, Kohne E, Bartram CR, Kleihauer E. Rapid and non-
radioactive prenatal diagnosis of beta thalassaemia and sickle cell
disease: application of the polymerase chain reaction (PCR). Br J
Haematol. 1988;70:455–8.
12. Woyessa A, Deressa W, Ali A, Lindtjørn B. Evaluation of CareStartTM malaria
Pf/Pv combo test for Plasmodium falciparum and Plasmodium vivax malaria
diagnosis in Butajira area, south-central Ethiopia. Malar J. 2013;12:218.
13. Hoffmann J, Rabezanahary H, Randriamarotia M, Ratsimbasoa A, Najjar J,
Vernet G, et al. Viral and atypical bacterial etiology of acute respiratory
infections in children under 5 years old living in a rural tropical area of
Madagascar. PLoS ONE. 2012;7, e43666.
14. Picot VS, Bénet T, Messaoudi M, Telles J-N, Chou M, Eap T, et al. Multicenter
case–control study protocol of pneumonia etiology in children: Global
Approach to Biological Research, Infectious diseases and Epidemics in Low-
income countries (GABRIEL network). BMC Infect Dis. 2014;14:635.
Maeder et al. BMC Hematology  (2016) 16:30 Page 9 of 915. WHO. WHO child growth standards. Length/height-for-age, weight-for-age,
weight-for-length, weight-for-height and body mass index-for-age: methods
and development. 2006.
16. Fourquet R, Sarthou JL, Roux J, Acri K. Haemoglobin S and stand origin of
Madagascar. New hypothesis on its introduction in Africa. Arch Inst Pasteur
Madagascar. 1974;43:185–220.
17. Hewitt R, Krause A, Goldman A, Campbell G, Jenkins T. Beta-globin
haplotype analysis suggests that a major source of Malagasy ancestry is
derived from Bantu-speaking Negroids. Am J Hum Genet. 1996;58:1303–8.
18. Sadarangani M, Makani J, Komba AN, Ajala-Agbo T, Newton CR, Marsh K,
Williams TN. An observational study of children with sickle cell disease in
Kilifi, Kenya. Br J Haematol. 2009;146:675–82.
19. Cox SE, Makani J, Fulford AJ, Komba AN, Soka D, Williams TN, et al.
Nutritional status, hospitalization and mortality among patients with sickle
cell anemia in Tanzania. Haematologica. 2011;96:948–53.
20. Hyacinth HI, Adekeye OA, Yilgwan CS. Malnutrition in sickle cell anemia:
implications for infection, growth, and maturation. J Soc Behav Health Sci.
2013;7:1.
21. McClish DK, Levenson JL, Penberthy LT, Roseff SD, Bovbjerg VE, Roberts JD,
et al. Gender differences in pain and healthcare utilization for adult sickle cell
patients: The PiSCES Project. J Womens Health (Larchmt). 2006;15:146–54.
22. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ. An analysis of fetal
hemoglobin variation in sickle cell disease: the relative contributions of the
X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender,
and age. Blood. 1995;85:1111–7.
23. Akre Charuhas V, Sukhsohale Neelam D, Kubde Sanjay S, Agrawal Sanjay B,
Khamgaokar Mohan B, Chaudhary Sanjeev M, et al. Do gender differences
influence the prevalence of sickle cell disorder and related morbidities
among school children in rural central India? Int J Collab Res Intern Med
Public Health. 2013;5:348–58.
24. Migot-Nabias F, Pelleau S, Watier L, Guitard J, Toly C, De Araujo C, et al. Red
blood cell polymorphisms in relation to Plasmodium falciparum
asymptomatic parasite densities and morbidity in Senegal. Microbes Infect.
2006;8:2352–8.
25. Shim E, Feng Z, Castillo-Chavez C. Differential impact of sickle cell trait on
symptomatic and asymptomatic malaria. Math Biosci Eng. 2012;9:877–98.
26. Steele RW, Warrier R, Unkel PJ, Foch BJ, Howes RF, Shah S, et al.
Colonization with antibiotic-resistant Streptococcus pneumoniae in children
with sickle cell disease. J Pediatr. 1996;128:531–5.
27. Kateete DP, Kajumbula H, Kaddu-Mulindwa DH, Ssevviri AK. Nasopharyngeal
carriage rate of Streptococcus pneumoniae in Ugandan children with sickle
cell disease. BMC Res Notes. 2012;5:28.
28. Joffe MD, Alpern ER. Occult pneumococcal bacteremia: a review. Pediatr
Emerg Care. 2010;26:448–54.
29. Strouse JJ, Reller ME, Bundy DG, Amoako M, Cancio M, Han RN, et al. Severe
pandemic H1N1 and seasonal influenza in children and young adults with
sickle cell disease. Blood. 2010;116:3431–4.
30. Sadreameli SC, Reller ME, Bundy DG, Casella JF, Strouse JJ. Respiratory
syncytial virus and seasonal influenza cause similar illnesses in children with
sickle cell disease. Pediatr Blood Cancer. 2014;61:875–8.
31. Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, et al.
Frequent detection of respiratory viruses without symptoms: toward
defining clinically relevant cutoff values. J Clin Microbiol. 2011;49:2631–6.
32. Jartti T, Jartti L, Peltola V, Waris M, Ruuskanen O. Identification of respiratory
viruses in asymptomatic subjects: asymptomatic respiratory viral infections.
Pediatr Infect Dis J. 2008;27:1103–7.
33. Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A, Shtainberg R,
Lieberman D. Respiratory viruses in adults with community-acquired
pneumonia. Chest. 2010;138:811–6.
34. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and
derived service indicators. Bull World Health Organ. 2008;86:480–7. •  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
